StockData
X4 Pharmaceuticals, Inc logo

X4 Pharmaceuticals, Inc (XFOR) stock

XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$2.83−0.29 (-9.29%)

Close on Nov 16, 2026Market cap $280.59MP/E –Yield –

Earnings

X4 Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2025
$1.77M
+194.2% on a year earlier
EPS, Q3 FY2025
-$0.69
-$0.18 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of X4 Pharmaceuticals's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2025ended Sep 30, 2025Nov 5, 2025before the open$1.77M+194.2%-$0.69Release
Q1 FY2025ended Mar 31, 2025May 1, 2025before the open$28.80M–$0.04Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open$1.40M–-$0.20Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open$600.00K–-$0.18Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open$600.00K–$0.45Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open––-$0.26Release
Q4 FY2023ended Dec 31, 2023Mar 21, 2024before the open–––Release
Q2 FY2023ended Jun 30, 2023Aug 10, 2023before the open–––Release
Q1 FY2023ended Mar 31, 2023May 4, 2023before the open––-$0.16Release
Q4 FY2022ended Dec 31, 2022Mar 21, 2023before the open––-$0.29Release
Q3 FY2022ended Sep 30, 2022Nov 3, 2022before the open––-$0.26Release
Q2 FY2022ended Jun 30, 2022Aug 4, 2022before the open––-$0.60Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

X4 Pharmaceuticals has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When X4 Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases X4 Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. Update
  3. News
  4. News
  5. Update
  6. Results
  7. Update
  8. News
  9. News
  10. Results
  11. Results
  12. News
  13. Results
  14. Update
  15. Update

See a number that looks wrong?